1 active not recruiting, 1 recruiting. 2 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Active not recruiting 1, Recruiting 1 |
Follow Avacta Life Sciences Ltd: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| AVA6103 in Subjects With Locally Advanced or Metastatic Selected Solid Tumors AVA6103 - Vulvar Adenocarcinoma, PDAC - Pancreatic Ductal Adenocarcinoma | Phase 1 | Recruiting | Avacta Life Sciences Ltd | 174 | 2026-03-31 | 2026-10-05 |
| A Study Evaluating the Safety, Pharmacokinetics and Early Efficacy of AVA6000 in Solid Tumours AVA6000 - Salivary Gland Tumor, Urothelial Carcinoma | Phase 1 | Active not recruiting | Avacta Life Sciences Ltd | 158 | 2021-07-16 | 2026-10-02 |
Breast Neoplasms (1) · Carcinoma, Transitional Cell (1) · Colorectal Neoplasms (1) · Ovarian Neoplasms (1) · Salivary Gland Neoplasms (1) · Sarcoma (1) · Small Cell Lung Carcinoma (1)
United States (2) · United Kingdom (1)